
The industry has a number of ways of explaining the potential health benefits of its products, from structure/function claims to full health claims. However, claims on labels, websites, at trade shows, and even twitter feeds are coming under increased scrutiny. In this topic category we bring all the news on claims together in one easily accessible section.
Differing regulatory environments can play havoc with a company's research plans, say consultant Joerg Gruenwald, PhD. But recent, sometimes bitter, experience with the European Food Safety Authority has shed some...
There are two speeds when it comes to energy products: Slow and fast, says Mintel trend-spotting guru David Jago.
The US Food and Drug Administration has issued warning letters to two dietary supplement companies, as the agency maintains its vigilance of website claims and cGMP compliance.
The US Food and Drug Administration has issued some important warning letters in recent weeks. In this special focus, we revisit the lessons for all companies, from website claims, to...
The FDA has issued a warning letter for a company website that links to articles with disease claims cause products to be drugs (FDA), causing the products linked to such...
The Center for Science in the Public Interest (CSPI) is threatening litigation against Bayer for alleged “deceptive practices in the marketing and sale of several lines of Bayer multivitamins”.
Next Pharmaceuticals has bolstered the stress-reducing credentials of its Relora branded ingredient with new research presented at the recent Experimental Biology conference in Boston.
A bill requiring the labeling of GMO ingredients has been introduced at the federal level by Sen. Barbara Boxer, D-CA and Rep. Peter DeFazio, D-OR. Even though the bill’s chances...
Are consumers experiencing superfruit fatigue? Depends on the fruit…and who you talk to.
Ashwagandha, sometimes called the “king” of ayurvedic herbs, has been gaining traction in the North American marketplace. A big part of the reason is the investments in clinical science and...
Lakeview Equity Partners, a Milwaukee-based investment firm, has taken its first dip into the human nutrition pool with the acquisition of probiotics supplier and finished goods manufacturer UAS Labs.
Two recent warning letters from the FDA should serve as a reminder to supplement makers that the agency is scrutinizing their activities on Facebook and Twitter just as carefully as it...
With antioxidants that are relatively new to the market, strong scientific evidence backing benefits and modes of action is crucial to constructing a coherent ingredient story, experts say. The tale...
Swedish firm Greenleaf Medical took the Best New Ingredient gong at the recent NutrAward presented at ExpoWest in Los Angeles for its weight management-focused, spinach extract Appethyl. Now it wants...
Regulations regarding how dietary supplement manufacturers can use testimonials to market their products have been on the books for many years now. But judging from recent warning letters and enforcement...
Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and...
FDA seized tainted dietary supplement products from a Florida company called Globe All Wellness, the agency said Friday.
Four dietary supplements have received independent warning letters from the Food and Drug Administration for alleged GMP violations, as the agency maintains its focus on compliance.
Despite a Food and Drug Administration (FDA) warning that a sibutramine-laced ‘Brazilian Slimming Coffee’ may pose a 'significant risk' to some US consumers, the product is still widely available online.
Emerson Ecologics, which markets a wide range of dietary supplements in the health practitioner channel, has taken on a new cognitive support product, Perceptiv by Sevo Nutraceuticals, attracted, a Sevo...
Utah-based Food for Health International, LLC, has received a warning letter from the Food and Drug Administration (FDA) for alleged disease claims and GMP violations.
Danish probiotics leader Chr Hansen, which ditched a €4m immunity trial for some of its probiotic strains last year, is participating in a new trial to determine if probiotics can...
While the headlines yesterday could be summarized as ‘FTC one, POM zero’, legal experts say the 54-page opinion from FTC Commissioners on the FTC’s false advertising case vs POM Wonderful...
A recent ruling by the US appeals court protecting free-speech relating to off-label use of pharmaceuticals may have ‘far reaching effects’ for the nutritional supplement business, says a leading industry...
As 2012 comes to a close, NutraIngredients-USA looks back on an action packed year. In the second of our series of galleries capturing the year’s main events, we take a...